Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Beginning Balance (in shares) at Dec. 31, 2020   76,457        
Beginning Balance at Dec. 31, 2020 $ 1,210,149 $ 765 $ 1,394,009 $ (204,112) $ 12,634 $ 6,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 51,216     51,024   192
Unrealized gain (loss) on available-for-sale securities (19,310)       (19,225) (85)
Unrealized gain (loss) on interest rate swaps 1,240       1,232 8
Issued shares of common stock (in shares)   1,639        
Issued shares of common stock 102,926 $ 16 102,910      
Equity-based compensation 4,678   2,639     2,039
Issuance (repurchase) of vested equity-based compensation shares (in shares)   223        
Issuance (repurchase) of vested equity-based compensation shares (10,388) $ 2 (10,390)      
Dividends and distributions (29,190)     (28,904)   (286)
Ending Balance (in shares) at Mar. 31, 2021   78,319        
Ending Balance at Mar. 31, 2021 1,311,321 $ 783 1,489,168 (181,992) (5,359) 8,721
Beginning Balance (in shares) at Dec. 31, 2020   76,457        
Beginning Balance at Dec. 31, 2020 1,210,149 $ 765 1,394,009 (204,112) 12,634 6,853
Ending Balance (in shares) at Dec. 31, 2021   85,327        
Ending Balance at Dec. 31, 2021 1,566,515 $ 853 1,727,667 (193,706) 9,904 21,797
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 45,703     45,346   357
Unrealized gain (loss) on available-for-sale securities (22,709)       (22,532) (177)
Unrealized gain (loss) on interest rate swaps 289       287 2
Issued shares of common stock (in shares)   1,050        
Issued shares of common stock 49,860 $ 10 49,850      
Equity-based compensation 3,541   962     2,579
Conversion of convertible notes (in shares)   283        
Conversion of convertible notes 7,674 $ 3 7,671      
Issuance (repurchase) of vested equity-based compensation shares (in shares)   60        
Issuance (repurchase) of vested equity-based compensation shares (2,211) $ 1 (2,212)      
Dividends and distributions (34,668)     (32,922)   (1,746)
Ending Balance (in shares) at Mar. 31, 2022   86,720        
Ending Balance at Mar. 31, 2022 $ 1,613,994 $ 867 $ 1,783,938 $ (181,282) $ (12,341) $ 22,812